Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.

Bansal, Dhruv; Vij, Kiran; Chang, Gue Su; Miller, Christopher A; DiPersio, John F; Vij, Ravi; Heath, Sharon E; Westervelt, Peter; Welch, John S; Fehniger, Todd A.
Haematologica; 103(6): e270-e273, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29567774